Vesugen: Dosage, Benefits & Side Effects

By Peptide Assistant Editorial Team · · · 8 sources cited

Overview

Vesugen is a synthetic tripeptide bioregulator (Lys-Glu-Asp) developed by the Khavinson group targeting vascular tissue. It is classified as a vessel wall bioregulator peptide designed to support and normalize vascular function at the gene expression level. Used in Russian gerontological medicine, vesugen is part of comprehensive vascular health programs for age-related circulatory decline.

Mechanism of Action

Vesugen is proposed to operate through the same general mechanism as other Khavinson bioregulators — direct interaction with DNA regulatory regions in target cells. In cultured vascular endothelial cells it raised the proliferation marker Ki-67, and in endothelium from patients with atherosclerosis and restenosis it normalized endothelin-1 and raised sirtuin-1 expression in vitro; effects on vascular smooth muscle or elastic fibers have not been reported. The tripeptide sequence is proposed to interact with histone proteins and DNA at specific loci, restoring gene expression patterns that shift during aging. This may include upregulation of elastin and collagen synthesis genes in the vessel wall and modulation of matrix metalloproteinase expression to optimize extracellular matrix turnover.

Vesugen Benefits: What the Research Shows

  • Khavinson et al. demonstrated that tripeptides of this class can interact with specific DNA sequences and modulate gene expression in cell culture
  • Two small uncontrolled Russian studies (41 patients each) reported better blood flow after vesugen monotherapy in patients operated on for chronic lower-limb ischemia and in men with vasculogenic erectile dysfunction (Advances in Gerontology, 2013 and 2014); no study of arterial compliance or pulse wave velocity was found
  • Studies on the broader Khavinson peptide family show tissue-specific effects on gene expression in multiple organ systems
  • Published Russian clinical reports on vesugen date from 2012 onward and are small

Vesugen Dosage

  • Standard protocol: 1–2 capsules daily for 10–30 days
  • Injectable form: 10 mcg subcutaneously every other day for 10–20 days
  • Repeat courses every 3–6 months
  • Take capsules on an empty stomach
  • Often combined with other vascular and cardiac bioregulators
  • Can be integrated into broader anti-aging bioregulator programs
Peptide calculator: get your dose in syringe units →

Disclaimer: Dosing information is compiled from research literature and community protocols for educational purposes only. This is not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol.

Vesugen Side Effects & Safety

Known Side Effects

  • Published studies are small and did not systematically record side effects; one study of 32 patients given vesugen or pinealon noted pro-oxidant activity and a fall in circulating CD34+ blood stem cell markers
  • Ultra-short peptide structure is assumed to limit immunogenicity and toxicity; neither has been formally tested
  • No cardiovascular adverse events documented
  • No long-term safety monitoring data have been published

Safety Profile

Vesugen has been used in Russian clinical practice without significant reported adverse effects. Its toxicity and immunogenicity have not been formally studied; one small study noted pro-oxidant activity and lower circulating CD34+ cell markers with vesugen and pinealon. Safety data is primarily from Russian-language publications and clinical experience rather than large Western randomized controlled trials. No contraindications are established. Compatibility with standard cardiovascular medications has not been studied.

What to Expect

Effects are subtle and cumulative. No dramatic acute effects. Over the course of treatment (10–30 days), vascular function may gradually improve at the cellular level. Measurable effects on vascular parameters may require multiple courses over months. Published clinical reports are limited to small studies in older patients with arterial disease. Benefits are proposed to accumulate with repeated courses.

Common Stacks

Storage & Handling

Store capsules at room temperature (15–25°C) in original packaging. Protect from moisture and light. Shelf life: 2–3 years. Injectable form: store lyophilized powder at 2–8°C.

Pricing & Available Variants

$60price range
20mg

Prices sourced from peptides.gg marketplace. Prices may vary.

References

Related Peptides

Track Vesugen in Your Protocol

Log your Vesugen doses, track consistency, and monitor your protocol with Peptide Assistant — completely free.

Start Tracking Free